Analysis of Gene Diagnosis of Thalassemia in Dali Bai Autonomous Prefecture of Yunnan
1.Genetic Testing Center,the First Affiliated Hospital of Dali University,Dali 671000,China
2.Department of Maieutics,Dali Bai Autonomous Prefecture People's Hospital,Dali 671000,China
*Corresponding author:WANG Guangming,Professor;E-mail:gmwang1991@hotmail.com
YANG Xitong,YANG Zongmei,MA Rong, et al. Analysis of Gene Diagnosis of Thalassemia in Dali Bai Autonomous Prefecture of Yunnan [J]. Chinese General Practice, 2019, 22(35): 4342-4345. DOI: 10.12114/j.issn.1007-9572.2019.00.254.
杨锡彤,杨宗梅,马蓉等. 云南省大理白族自治州地中海贫血基因诊断结果分析[J]. 中国全科医学, 2019, 22(35): 4342-4345. DOI: 10.12114/j.issn.1007-9572.2019.00.254.
[1]韦媛,林丽,陈碧艳,等.广西地区中国型Gγ(Aγδβ)0-TM的发病情况及表型特征[J].山东医药,2016,56(37):58-60.DOI:10.3969/j.issn.1002-266X.2016.37.019.http://www.cnki.com.cn/Article/CJFDTotal-SDYY201637023.htm.
[2]WEATHERALL D J.The evolving spectrum of the epidemiology of thalassemia[J].Hematol Oncol Clin North Am,2018,32(2):165-175.DOI:10.1016/j.hoc.2017.11.008.
[3]KEIKHAEI B,SLEHI-FARD P,SHARIATI G,et al.Genetics of Iranian alpha-thalassemia patients:a comprehensive original study[J].Biochem Genet,2018,56(5):506-521.
[4]胡俊杰,陈鑫苹,王洁,等.海南黎族中学生地中海贫血流行现状及罕见基因型研究[J].广东医学,2018,39(10):1471-1477.DOI:10.13820/j.cnki.gdyx.20180611.009.http://www.cnki.com.cn/Article/CJFDTotal-GAYX201810009.htm.
[5]张莉,叶国永,黄国珍,等.深圳市TM患者基因诊断结果分析[J].中国全科医学,2012,15(23):2677-2678.DOI:10.3969/j.issn.1007-9572.2012.08.061.
ZHANG L,YE G Y,HUANG G Z,et al.Thalassemia in Shenzhen:a genotypic analysis of 189 cases[J].Chinese General Practice,2012,15(23):2677-2678.DOI:10.3969/j.issn.1007-9572.2012.08.061.
[6]HIGGS D R,ENGEL J D,STAMATOYANNOPOULOS G.Thalassaemia[J].Lancet,2012,379(9813):373-383.
[7]WEATHERALL D J.The challenge of haemoglobinopathies in resource-poor countries[J].Br J Haematol,2011,154(6):736-744.DOI:10.1111/j.1365-2141.2011.08742.x.
[8]METTANANDA S,HIGGS D R.Molecular basis and genetic modifiers of thalassemia[J].Hematol Oncol Clin North Am,2018,32(2):177-191.DOI:10.1016/j.hoc.2017.11.003.
[9]THEIN S L.Molecular basis of β thalassemia and potential therapeutic targets[J].Blood Cells Mol Dis,2018,70(5):54-65.DOI:10.1016/j.bcmd.2017.06.001.
[10]ZHANG J,HE J,MAO X Q,et al.Haematological and electrophoretic characterisation of β-thalassaemia in Yunnan Province of Southwestern China[J].BMJ Open,2017,7(1):e013367.DOI:10.1136/bmjopen-2016-013367.
[11]XU X M,ZHOU Y Q,LUO G X,et al.The prevalence and spectrum of alpha and beta thalassaemia in Guangdong Province:implications for the future health burden and population screening[J].J Clin Pathol,2004,57(5):517-522.
[12]ZHANG J,ZHU B S,HE J,et al.The spectrum of α- and β-thalassemia mutations in Yunnan Province of Southwestern China[J].Hemoglobin,2012,36(5):464-473.
[13]XIONG F,SUN M,ZHANG X,et al.Molecular epidemiological survey of haemoglobinopathies in the Guangxi Zhuang Autonomous Region of Southern China[J].Clin Genet,2010,78(2):139-148.DOI:10.1111/j.1399-0004.2010.01430.x.
[14]HE S,LI J H,LI D M,et al.Molecular characterization of α- and β-thalassemia in the Yulin Region of Southern China[J].Gene,2018,655(20):61-64.DOI:10.1016/j.gene.2018.02.058.
[15]ORIGA R.β-thalassemias[J].Genet Med,2017,19(6):609-619.DOI:10.1038/gim.2016.173.
[16]MOHAMED S Y.Thalassemia major:transplantation or transfusion and chelation[J].Hematol Oncol Stem Cell Ther,2017,10(4):290-298.DOI:10.1016/j.hemonc.2017.05.022.
[17]FINOTTI A,BORGATTI M,GAMBARI R.Ground state na?ve pluripotent stem cells and CRISPR/Cas9 gene correction for β-thalassemia[J].Stem Cell Investig,2016,10(3):66.